Questions and answers

How many chemotherapy sessions will I need?

What the number of sessions and cycles depends on, with some real examples from studies

Updated: 28 October 20262 min read5 references
Show content for:
Short answer

There is no fixed number of chemotherapy sessions; it depends on the type and stage of the cancer, the drugs, the aim of treatment (cure, control or easing symptoms) and how your body responds [1]. Chemotherapy is usually given in "cycles": a few days of treatment followed by rest so that healthy cells can recover [1]. For example, treatment after surgery for stage 3 bowel cancer is usually 3 or 6 months, treatment for low-risk lymphoma 4 to 6 cycles, and chemotherapy for prostate cancer that has spread 6 cycles [2, 3, 4].

What does a chemotherapy "cycle" mean?

Most patients receive chemotherapy in cycles. Each cycle includes a period when the drug is given, followed by a rest period so the body has a chance to recover and make new healthy cells [1]; for example, one week of treatment and three weeks of rest make up a 4-week cycle [1]. So the "number of sessions" is not the same as the "number of cycles": one cycle may involve one day of infusion or several days of treatment.

Chemotherapy is mostly given intravenously (by drip), but there are also tablets, injections under the skin or into a muscle, and other routes. Some patients receive treatment through a port or catheter, and sometimes with a portable pump at home [1].

Diagram of an implanted port being accessed with a special needle
An implanted port: a small reservoir placed under the skin of the chest in a minor operation, with a tube leading to a large vein. At each session, chemotherapy is given into the port through the skin with a special needle, so fewer needles are needed in the arm.Image: Cancer Research UK · CC BY-SA 4.0 · Wikimedia Commons (adapted: Persian labels)
Diagram of a PICC line running from an arm vein to near the heart
A PICC line: a thin tube inserted through a vein in the arm, with its tip reaching a large vein near the heart. For longer courses of treatment it can stay in place for several months.Image: Cancer Research UK · CC BY-SA 4.0 · Wikimedia Commons (adapted: Persian labels)

How many cycles? Examples from large studies

Examples of the length of chemotherapy in some common situations
SituationTreatmentLengthWhat was shown
Stage 3 bowel cancer after surgeryCAPOX or FOLFOX3 or 6 monthsIn lower-risk patients, 3 months of CAPOX was as effective as 6 months [2]
Low-risk B-cell lymphoma (age 18 to 60, stage 1 or 2)R-CHOP every 3 weeks4 or 6 cycles4 cycles were as good as 6 cycles, with fewer side effects [3]
Prostate cancer that has spreadDocetaxel with hormone therapy6 cycles, every 3 weeksPatients lived about a year longer [4]

This table is for information only; the treating doctor decides each patient's plan.

For physiciansSpecialist notes
For physicians

Why is shorter treatment sometimes enough? In colorectal cancer, oxaliplatin causes cumulative neurotoxicity, and shortening treatment can reduce side effects and cost. In the IDEA analysis of more than 12,000 patients, in lower-risk patients (T1 to T3 and N1) 3-year disease-free survival was 83.1% with 3 months of treatment and 83.3% with 6 months; but in higher-risk patients (T4 or N2), six months of treatment was superior [2]. In the FLYER trial, reducing the number of cycles was also associated with less haematological and non-haematological toxicity [3].

What might change the plan?

  • Blood counts: during a chemotherapy cycle there are times when the number of white blood cells (neutrophils) is low; this is why blood tests are done before cycles [5].
  • Side effects: it is best not to miss any treatment, but sometimes the doctor changes the plan because of side effects and explains when treatment will restart [1].
  • Response to treatment: examinations, blood tests and scans (MRI, CT or PET) show whether treatment is working [1].

When should I see a doctor straight away?

If during chemotherapy you have a temperature of 38 °C or higher, chills, a cough or sore throat, diarrhoea, burning or blood in the urine, sores or a white coating in the mouth, or redness and swelling where a catheter enters the skin, contact your treatment team straight away. Infection during treatment can be life-threatening; talk to your doctor before taking any medicine for fever (even paracetamol or ibuprofen), because it may hide the signs of a serious problem [5].

Related questions

If a chemotherapy session is delayed, will the treatment stop working?

It is best not to miss a session, but sometimes the doctor changes the plan because of side effects; in that case the treatment team will explain what to do and when to restart [1].

Do more side effects mean chemotherapy is working better?

No. Side effects are not related to how well chemotherapy is working against the cancer; having no side effects does not mean the treatment is not working [1].

Can I work during chemotherapy?

Many people can, as long as they adjust their work to how they feel; for example working part-time or from home on harder days [1].

Scientific evidence

Key studies in the evidence library

2 items
Clinical trial

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

N Engl J Med · 2018
HR 1.07Overall population (3 vs 6 months)
Clinical trial · Phase 3

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

N Engl J Med · 2015
57.6 vs 44.0 monthsMedian overall survival

References

5 references
Show all references, 3 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Chemotherapy to Treat CancerNational Cancer Institute · cancer.gov · 2025
    Source Back to text: 1 2 3 4 5 6 7 8 9 10
  2. 2
    Duration of Adjuvant Chemotherapy for Stage III Colon CancerGrothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, et al · N Engl J Med · 2018;378:1177-1188
    Study cardDOIPubMed Back to text: 1 2 3
  3. 3
    Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trialPoeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, et al · The Lancet · 2019;394:2271-2281
    Study cardDOIPubMed Back to text: 1 2 3
  4. 4
    Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerSweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, et al · N Engl J Med · 2015;373:737-746
    Study cardDOIPubMed Back to text: 1 2
  5. 5
    Infection and Neutropenia during Cancer TreatmentNational Cancer Institute · cancer.gov · 2020
    Source Back to text: 1 2

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.